BIRMINGHAM, Ala., Oct. 5, 2020 /PRNewswire/ — Encompass Health Corporation (NYSE: EHC) issued notice for redemption of all $700 million in outstanding principal balance of its 5.75% senior notes due 2024 (the «2024 Notes»). Pursuant to the terms of the 2024 Notes, this full redemption will settle on Nov. 1, 2020 and will be made at a price of par. The Company plans to use the net proceeds from its recent public offering of $400 million of senior unsecured notes due 2031 (the «2031 Notes»), which is scheduled to close on Oct. 5, 2020, together with available cash on hand, to fund the redemption.
About Encompass Health
As a national leader in integrated healthcare services, Encompass Health (NYSE: EHC) offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 136 hospitals, 245 home health locations, and 83 hospice locations in 39 states and Puerto Rico, the Company is committed to delivering high-quality, cost-effective, integrated care across the healthcare continuum. Encompass Health is ranked as one of Fortune’s 100 Best Companies to Work For.
Statements contained in this press release which are not historical facts, such as the completion of this redemption and the closing of the offering of the 2031 Notes, are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, Encompass Health’s ability to complete the redemption as described or at all; the impact of the COVID-19 pandemic on Encompass Health’s operations, business, and financial condition, as well as its potential negative impact on Encompass Health’s liquidity, particularly if the operations of acute-care hospitals and physician practices remain disrupted for a significant amount of time; Encompass Health’s ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving Encompass Health, including any matters related to yet undiscovered issues, if any, at acquired companies; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health’s or a vendor’s or partner’s information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health’s services by governmental or private payors; general conditions in the economy and capital markets, including any disruption, instability or uncertainty related to armed conflict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase to the debt ceiling, an international trade war or sovereign debt crisis, or a widespread outbreak of a contagious disease; and other factors which may be identified from time to time in Encompass Health’s SEC filings and other public announcements, including Encompass Health’s Form 10-K for the year ended Dec. 31, 2019 and Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020.
Hillary Carnel | 205 970-5912
Investor Relations Contact:
Crissy Carlisle | 205 970-5860
View original content to download multimedia:http://www.prnewswire.com/news-releases/encompass-health-issues-notice-for-full-redemption-of-remaining-700-million-of-its-5-75-senior-notes-due-2024–301145561.html
SOURCE Encompass Health Corp.